Sponsored Links
| Concert Pharmaceuticals Presents Preclinical Data On Novel Deuterium-Containing Drug Compound At Antiepileptic Drug Trials XI Conference |
 |
 |
 |
| Medical News - Epilepsy | |||
|
Concert Pharmaceuticals, Inc. announced that C-10068, a novel deuterium-containing sigma-1 agonist, was found to have activity in preclinical models of epilepsy, neuroprotection and neuropathic pain. C-10068 is based on a molecule that was reported to have preclinical anti-convulsant efficacy, but was limited by poor metabolic stability resulting in low oral bioavailability... Read more: Epilepsy News From Medical News Today
|